triGUT™
– The worlds most well documented probiotic complex
The complex is combination of three specific and world famous strains which, when administered in adequate volume offers superior clinical effects
| Lactiplantibacillus plantarum DSM 9843 |
| Lacticaseibacillus rhamnosus GG ATCC 53103 |
| Bifidobacterium animalis spp lactis DSM 15954 |
When choosing a probiotic solution for your consumer brand you do not want to make compromises. Digestive health matters the most to consumers (70% according to Lumina / Euromonitor). A consumer needs to experience “the difference” in a health area that is important to them, and triGUT™ delivers.
triGUT™ was launched in Sweden 2022 with a clear value proposition covering the family’s full digestive needs in one product – Infants, children and adults – male and female.
Clinical Evidence
Taken together, the probiotic strains included in triGUT™, have been documented in more than 1200 published scientific studies of which more than 350 are clinical trials. triGUT™ brings several important health benefits in digestive health. It is estimated that 70% of consumers search for probiotics to help them with their gut health. triGUT™ is the worlds most documented probiotic complex and with extensive digestive health clinical documentation in the most important areas – examples:
Abdominal pain and bloating
52% reduction of abdominal pain and 78% estimated treatment effectiveness in IBS patients (double blind placebo-controlled trial with 214 participants, p<0.05). >50% reduction of bloating in 44% of IBS patients (double blind placebo-controlled trial with 60 participants, p<0.05)
Decreased infant cholic symptoms (Randomized controlled trial with 80 participants, p<0.05)
Diarrhea
54% reduction of children with gastroenteritis experiencing diarrhea episodes compared with placebo (double blind, placebo controlled randomized trial with 124 children, p>0.05)
Constipation
Weekly changes from baseline in defecation frequency (intention-to-treat population). Defecation frequency recorded in subject diaries and reported as days per week with significantly different from placebo group at weeks 2, 3 and 4 (**P<0.01). CFU, colony-forming units 1 billion CFU, n 343, Placebo n 453.
With triGUT™, consumers do not need to search
for different solutions but can rely on one optimal supplement for all of their gut health needs.
